HUP0400799A3 - Pharmaceutical formulation having a masked taste and method for the production thereof - Google Patents

Pharmaceutical formulation having a masked taste and method for the production thereof

Info

Publication number
HUP0400799A3
HUP0400799A3 HU0400799A HUP0400799A HUP0400799A3 HU P0400799 A3 HUP0400799 A3 HU P0400799A3 HU 0400799 A HU0400799 A HU 0400799A HU P0400799 A HUP0400799 A HU P0400799A HU P0400799 A3 HUP0400799 A3 HU P0400799A3
Authority
HU
Hungary
Prior art keywords
production
pharmaceutical formulation
masked taste
masked
taste
Prior art date
Application number
HU0400799A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of HUP0400799A2 publication Critical patent/HUP0400799A2/hu
Publication of HUP0400799A3 publication Critical patent/HUP0400799A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU0400799A 2001-06-21 2002-06-21 Pharmaceutical formulation having a masked taste and method for the production thereof HUP0400799A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0108157A FR2826274B1 (fr) 2001-06-21 2001-06-21 Formulation pharmaceutique au gout masque et son procede de preparation
PCT/FR2002/002158 WO2003000225A2 (fr) 2001-06-21 2002-06-21 Formulation pharmaceutique au gout masque et son procede de preparation

Publications (2)

Publication Number Publication Date
HUP0400799A2 HUP0400799A2 (hu) 2004-08-30
HUP0400799A3 true HUP0400799A3 (en) 2012-08-28

Family

ID=8864587

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0400799A HUP0400799A3 (en) 2001-06-21 2002-06-21 Pharmaceutical formulation having a masked taste and method for the production thereof

Country Status (41)

Country Link
US (2) US7138138B2 (OSRAM)
EP (1) EP1401397B1 (OSRAM)
JP (1) JP4880871B2 (OSRAM)
CN (1) CN1239149C (OSRAM)
AP (1) AP1595A (OSRAM)
AR (1) AR036096A1 (OSRAM)
AT (1) ATE290366T1 (OSRAM)
AU (1) AU2002329311B2 (OSRAM)
BG (1) BG66314B1 (OSRAM)
BR (1) BRPI0208998A2 (OSRAM)
CA (1) CA2452239C (OSRAM)
CO (1) CO5540278A2 (OSRAM)
CZ (1) CZ299947B6 (OSRAM)
DE (1) DE60203178T2 (OSRAM)
EA (1) EA006016B1 (OSRAM)
EC (1) ECSP034915A (OSRAM)
ES (1) ES2236574T3 (OSRAM)
FR (1) FR2826274B1 (OSRAM)
GT (2) GT200200115AA (OSRAM)
HR (1) HRP20031067B1 (OSRAM)
HU (1) HUP0400799A3 (OSRAM)
IL (2) IL159404A0 (OSRAM)
JO (1) JO2325B1 (OSRAM)
MA (1) MA27042A1 (OSRAM)
MX (1) MXPA03011756A (OSRAM)
MY (1) MY134340A (OSRAM)
NO (1) NO332258B1 (OSRAM)
NZ (1) NZ530042A (OSRAM)
OA (1) OA12635A (OSRAM)
PA (1) PA8548301A1 (OSRAM)
PE (1) PE20030201A1 (OSRAM)
PL (1) PL202090B1 (OSRAM)
PT (1) PT1401397E (OSRAM)
SK (1) SK285865B6 (OSRAM)
SV (1) SV2003001098A (OSRAM)
TN (1) TNSN03141A1 (OSRAM)
TW (1) TWI228049B (OSRAM)
UA (1) UA77960C2 (OSRAM)
UY (1) UY27341A1 (OSRAM)
WO (1) WO2003000225A2 (OSRAM)
ZA (1) ZA200309479B (OSRAM)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
GB2419094A (en) * 2004-10-12 2006-04-19 Sandoz Ag Pharmaceutical composition of unpleasnt tasing active substances
FR2882522B1 (fr) * 2005-02-25 2007-04-13 Aventis Pharma Sa Composition pharmaceutique solide comprenant de la telithromycine
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US20060264386A1 (en) * 2005-05-17 2006-11-23 Rongqi Sun Pharmaceutical formulations of 6-11 bicyclic ketolide derivatives and related macrolides and methods for preparation thereof
US20090011007A1 (en) * 2006-02-03 2009-01-08 Evonik Roehm Gmbh Pharmaceutical Compositions Containing Mixtures of Polymers and Active Agents Poorly Soluble in Water
WO2007108010A2 (en) * 2006-03-21 2007-09-27 Jubilant Organosys Limited Taste masked pharmaceutical composition for oral solid dosage form and process for preparing the same using magnesium aluminium silicate
US20080181932A1 (en) * 2007-01-30 2008-07-31 Drugtech Corporation Compositions for oral delivery of pharmaceuticals
KR100935893B1 (ko) * 2007-09-11 2010-01-07 국방과학연구소 1,1'-다이메틸-5,5’-바이테트라졸의 합성방법
CA2703475A1 (en) 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
DK2379635T3 (en) 2008-12-16 2016-12-05 Carlsberg As Cellulosic polymer material
KR20140139083A (ko) 2012-03-27 2014-12-04 셈프라 파마슈티컬스, 인크. 마크롤라이드계 항생제를 투여하기 위한 비경구 제제
DE102012014848A1 (de) * 2012-07-27 2012-10-31 Heilerde-Gesellschaft Luvos Just GmbH & Co. KG Heilerde-Zubereitung
AU2015301154A1 (en) * 2014-08-05 2017-02-23 Cempra Pharmaceuticals, Inc. Powder oral suspension formulations of antibacterial agents
US10982177B2 (en) 2017-09-18 2021-04-20 The Clorox Company Cleaning wipes with particular lotion retention and efficacy characteristics
CN114209661B (zh) * 2022-02-21 2022-04-29 北京罗诺强施医药技术研发中心有限公司 呈细粒形式的固体药物组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2930409A1 (de) * 1979-07-26 1981-02-12 Bayer Ag Spruehtrocknung von mikrokapseldispersionen
JPS63150220A (ja) * 1986-12-15 1988-06-22 Dainippon Pharmaceut Co Ltd 経口用固形製剤の製造方法
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
ZA945944B (en) * 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
US6153220A (en) * 1997-10-03 2000-11-28 Elan Corporation, Plc Taste-masked formulations
IN191239B (OSRAM) * 1999-06-11 2003-10-11 Ranbaxy Lab Ltd
US6555569B2 (en) * 2000-03-07 2003-04-29 Pfizer Inc. Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection
US6740642B2 (en) * 2000-08-22 2004-05-25 Basilea Parmaceutica Ag Macrolides with antibacterial activity

Also Published As

Publication number Publication date
OA12635A (fr) 2006-06-15
EA006016B1 (ru) 2005-08-25
CZ299947B6 (cs) 2009-01-07
EP1401397B1 (fr) 2005-03-09
EP1401397A2 (fr) 2004-03-31
PA8548301A1 (es) 2003-09-05
IL159404A (en) 2007-08-19
PL366803A1 (en) 2005-02-07
BRPI0208998A2 (pt) 2017-06-06
CZ20033441A3 (en) 2004-03-17
WO2003000225A3 (fr) 2003-03-13
GT200200115AA (es) 2005-01-12
IL159404A0 (en) 2004-06-01
TWI228049B (en) 2005-02-21
CA2452239C (fr) 2011-07-19
GT200200115A (es) 2003-02-27
ECSP034915A (es) 2004-02-26
PL202090B1 (pl) 2009-06-30
ZA200309479B (en) 2005-04-26
DE60203178T2 (de) 2006-01-26
JP2004534810A (ja) 2004-11-18
HRP20031067B1 (en) 2011-10-31
UA77960C2 (en) 2007-02-15
US7138138B2 (en) 2006-11-21
PE20030201A1 (es) 2003-03-12
DE60203178D1 (de) 2005-04-14
PT1401397E (pt) 2005-05-31
MXPA03011756A (es) 2004-07-01
ES2236574T3 (es) 2005-07-16
HRP20031067A2 (en) 2004-04-30
JP4880871B2 (ja) 2012-02-22
JO2325B1 (en) 2006-06-28
TNSN03141A1 (fr) 2005-12-23
SK285865B6 (sk) 2007-10-04
HK1067558A1 (en) 2005-04-15
AP1595A (en) 2006-04-12
WO2003000225A2 (fr) 2003-01-03
ATE290366T1 (de) 2005-03-15
AP2003002927A0 (en) 2003-12-31
NO20035581D0 (no) 2003-12-15
FR2826274B1 (fr) 2003-09-26
CO5540278A2 (es) 2005-07-29
US20070014857A1 (en) 2007-01-18
US20040142029A1 (en) 2004-07-22
MA27042A1 (fr) 2004-12-20
BG108458A (bg) 2005-02-28
MY134340A (en) 2007-12-31
SV2003001098A (es) 2003-03-18
CN1239149C (zh) 2006-02-01
SK15922003A3 (sk) 2004-05-04
FR2826274A1 (fr) 2002-12-27
AR036096A1 (es) 2004-08-11
BG66314B1 (bg) 2013-04-30
NZ530042A (en) 2005-09-30
CN1529585A (zh) 2004-09-15
NO332258B1 (no) 2012-08-13
EA200400061A1 (ru) 2004-06-24
UY27341A1 (es) 2003-01-31
AU2002329311B2 (en) 2007-02-01
CA2452239A1 (fr) 2003-01-03
HUP0400799A2 (hu) 2004-08-30

Similar Documents

Publication Publication Date Title
IL159031A0 (en) Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments
AU2003259417A1 (en) Taste masked dosage forms and processes for their preparation
AU2002344151A1 (en) Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments
AU2002303973A1 (en) Pharmaceutical dispensing apparatus and method
EP1478345A4 (en) NOVEL PHARMACEUTICAL DOSAGE FORMS AND PROCESS FOR PRODUCTION OF SAID DOSAGE FORMS
AU2002251612A1 (en) Stent and method for the production thereof (variants)
ZA200309479B (en) Pharmaceutical formulation having a masked taste and method for the production thereof
HUP0401200A3 (en) Pharmaceutical compositiuons containing terbinafin and process for producing them
AU2002329311A1 (en) Pharmaceutical formulation having a masked taste and method for the production thereof
GB0009349D0 (en) Shell-type confectionery product and method for manufacturing the same
HUP0105345A3 (en) Amlodipine bezylate tablets having extended stability and process for producing the same
SI1581258T1 (sl) Farmacevtska formulacija in postopek za njeno izdelavo
AU2002242685A1 (en) Creamy foodstuff and method for production thereof
MXPA03006501A (es) Producto alimenticio cremoso y metodo para su eleboracion.
AU2003281698A8 (en) 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof
AU2001289844A1 (en) Amifostine-monohydrate and a method for the production thereof
SI1401397T1 (en) Pharmaceutical formulation having a masked taste and method for the production thereof
PL375762A1 (en) Nasallly applicable pharmaceutical preparation and the production thereof
AU2001282071A1 (en) Multiparticulate pharmaceutical dosage form and a method for producing the same
AU2002363843A1 (en) Packing material and method for the production thereof
AU2002250813A1 (en) Pesticide and method for the production thereof
EP1374702A4 (en) FLAVORS AND METHOD FOR THEIR PRODUCTION
GB0112640D0 (en) Process and product
AU2002342493A1 (en) Angular decoration-holding device and method for the production thereof
AU2001265761A1 (en) Capacitor and method for the production thereof

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees